These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37913954)

  • 41. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
    Michalski JM; Roach M; Merrick G; Anscher MS; Beyer DC; Lawton CA; Lee WR; Pollack A; Rosenthal SA; Vijayakumar S; Carroll PR
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):667-72. PubMed ID: 19386445
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.
    Eade TN; Horwitz EM; Ruth K; Buyyounouski MK; D'Ambrosio DJ; Feigenberg SJ; Chen DY; Pollack A
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):338-45. PubMed ID: 18207665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
    Lawton CA; Bae K; Pilepich M; Hanks G; Shipley W
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):437-41. PubMed ID: 17881145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
    Lawton CA; Michalski J; El-Naqa I; Buyyounouski MK; Lee WR; Menard C; O'Meara E; Rosenthal SA; Ritter M; Seider M
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):383-7. PubMed ID: 18947938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study.
    Jorgo K; Polgar C; Major T; Stelczer G; Herein A; Pocza T; Gesztesi L; Agoston P
    Pathol Oncol Res; 2020 Apr; 26(2):905-912. PubMed ID: 30888646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing Generative Pretrained Transformers (GPT) in Clinical Decision-Making: Comparative Analysis of GPT-3.5 and GPT-4.
    Lahat A; Sharif K; Zoabi N; Shneor Patt Y; Sharif Y; Fisher L; Shani U; Arow M; Levin R; Klang E
    J Med Internet Res; 2024 Jun; 26():e54571. PubMed ID: 38935937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radical external beam radiotherapy for prostate cancer in Japan: preliminary results of the changing trends in the Patterns of Care process survey between 1996-1998 and 1999-2001.
    Ogawa K; Nakamura K; Sasaki T; Yamamoto T; Koizumi M; Inoue T; Teshima T;
    Jpn J Clin Oncol; 2004 Mar; 34(3):131-6. PubMed ID: 15078908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
    Holch P; Henry AM; Davidson S; Gilbert A; Routledge J; Shearsmith L; Franks K; Ingleson E; Albutt A; Velikova G
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):495-510. PubMed ID: 28126299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
    Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
    J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Learning curve in the application of a hydrogel spacer to protect the rectal wall during radiotherapy of localized prostate cancer.
    Pinkawa M; Klotz J; Djukic V; Schubert C; Escobar-Corral N; Caffaro M; Piroth MD; Holy R; Eble MJ
    Urology; 2013 Oct; 82(4):963-8. PubMed ID: 24074991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of machine learning methods for prediction of acute toxicity in organs at risk following prostate radiotherapy.
    Pella A; Cambria R; Riboldi M; Jereczek-Fossa BA; Fodor C; Zerini D; Torshabi AE; Cattani F; Garibaldi C; Pedroli G; Baroni G; Orecchia R
    Med Phys; 2011 Jun; 38(6):2859-67. PubMed ID: 21815361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Evaluation of Aeyeconsult: A Novel Ophthalmology Chatbot Leveraging Verified Textbook Knowledge and GPT-4.
    Singer MB; Fu JJ; Chow J; Teng CC
    J Surg Educ; 2024 Mar; 81(3):438-443. PubMed ID: 38135548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N; Small C; MacKenzie M; Yee D; Parliament M; Ghosh S; Mihai A; Amanie J; Murtha A; Field C; Murray D; Fallone G; Pearcey R
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):57-64. PubMed ID: 19395192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
    Yeoh EE; Fraser RJ; McGowan RE; Botten RJ; Di Matteo AC; Roos DE; Penniment MG; Borg MF
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):943-55. PubMed ID: 12605972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
    Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
    World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two Specialists, Two Recommendations: Discordance Between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
    Delaney RK; Sisco-Taylor BL; Wang X; Scherr K; Ubel PA; Haaland B; Kahn VC; Hamstra D; Wei JT; Madanay F; Davis JK; Greeno TU; Fagerlin A
    Urology; 2022 Nov; 169():156-161. PubMed ID: 35768027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physician and Artificial Intelligence Chatbot Responses to Cancer Questions From Social Media.
    Chen D; Parsa R; Hope A; Hannon B; Mak E; Eng L; Liu FF; Fallah-Rad N; Heesters AM; Raman S
    JAMA Oncol; 2024 Jul; 10(7):956-960. PubMed ID: 38753317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.